State legal innovations to encourage naloxone dispensing

Rudd, 2016, Increases in drug and opioid overdose deaths—United States, 2000-2014, MMWR Morb Mortal Wkly Rep, 64, 1378, 10.15585/mmwr.mm6450a3

Chamberlain, 1994, A comprehensive review of naloxone for the emergency physician, Am J Emerg Med, 12, 650, 10.1016/0735-6757(94)90033-7

van Dorp, 2007, Naloxone treatment in opioid addiction: the risks and benefits, Expert Opin Drug Saf, 6, 125, 10.1517/14740338.6.2.125

Michiels, 2004, Physiological and pathological responses to hypoxia, Am J Pathol, 164, 1875, 10.1016/S0002-9440(10)63747-9

Davis, 2014, Emergency medical services naloxone access: a national systematic legal review, Acad Emerg Med, 21, 1173, 10.1111/acem.12485

Lim, 2016, Prescribe to prevent: overdose prevention and naloxone rescue kits for prescribers and pharmacists, J Addict Med, 10, 300

2014

Davis, 2015, Legal changes to increase access to naloxone for opioid overdose reversal in the United States, Drug Alcohol Depend, 157, 112, 10.1016/j.drugalcdep.2015.10.013

2016

Jones, 2016, Increase in naloxone prescriptions dispensed in US retail pharmacies since 2013, Am J Public Health, 106, 689, 10.2105/AJPH.2016.303062

Green, 2015, Orienting patients to greater opioid safety: models of community pharmacy-based naloxone, Harm Reduct J, 12, 25, 10.1186/s12954-015-0058-x

Davis, 2015, Legal interventions to reduce overdose mortality: naloxone access and overdose Good Samaritan laws, Network for Public Health Law

Code of Federal Regulations. Title 21 C.F.R. Section 1306.04.

Blake, 2012, When is a patient-physician relation established?, AMA J Ethics, 14, 4

Beletsky, 2007, Physicians’ knowledge of and willingness to prescribe naloxone to reverse accidental opiate overdose: challenges and opportunities, J Urban Health, 84, 126

Binswanger, 2015, Overdose education and naloxone for patients prescribed opioids in primary care: a qualitative study of primary care staff, J Gen Intern Med, 30, 1837, 10.1007/s11606-015-3394-3

Hogben, 2005, Patient-delivered partner therapy for sexually transmitted diseases as practiced by U.S. physicians, Sex Transm Dis, 32, 101, 10.1097/01.olq.0000151417.43230.18

Workowski, 2015, Sexually transmitted diseases treatment guidelines, 2015, MMWR Recomm Rep, 64, 1

Kissinger, 2014, Expedited partner therapy for sexually transmitted diseases—are we there yet?, Sex Transm Dis, 41, 695, 10.1097/OLQ.0000000000000207

Cramer, 2013, The legal aspects of expedited partner therapy practice: do state laws and policies really matter?, Sex Transm Dis, 40, 657, 10.1097/01.OLQ.0000431358.18959.d4

2016

2016, CVS Health to offer naloxone without prescription in 23 states by month’s end, Drug Store News

2016

Clause, 2001, Prescribing privileges among pharmacists in Veterans Affairs medical centers, Am J Health Syst Pharm, 58, 1143, 10.1093/ajhp/58.12.1143

1996

Wermeling, 2015, Review of naloxone safety for opioid overdose: practical considerations for new technology and expanded public access, Ther Adv Drug Saf, 6, 20, 10.1177/2042098614564776

Davis, 2015, Engaging law enforcement in overdose reversal initiatives: authorization and liability for naloxone administration, Am J Public Health, e1

Davis, 2016, Co-prescribing naloxone does not increase liability risk, Subst Abuse, 37, 498, 10.1080/08897077.2016.1238431

Burris, 2001, Legal aspects of providing naloxone to heroin users in the United States, In J Drug Policy, 12, 237, 10.1016/S0955-3959(01)00080-9

North Carolina General Statutes, Section 1A-1, Rule 9. N.C.G.S. § 1A-1 Rule 9. Available at: http://www.ncleg.net/gascripts/statutes/StatutesTOC.pl?Chapter=0001A. Accessed January 3, 2017.

Cicero, 2015, Shifting patterns of prescription opioid and heroin abuse in the United States, N Engl J Med, 373, 1789, 10.1056/NEJMc1505541

Cicero, 2014, Driven by prescription drug abuse, heroin use increases among suburban and rural whites, JAMA, 312, 118, 10.1001/jama.2014.7404

Tesoriero, 2009, Expanding access to sterile syringes through pharmacies: assessment of New York’s Expanded Syringe Access Program, J Am Pharm Assoc (2003), 49, 407, 10.1331/JAPhA.2009.07127

Rich, 2002, Pharmacist support for selling syringes without a prescription to injection drug users in Rhode Island, J Am Pharm Assoc, 42, S58

Dowell, 2016, CDC guideline for prescribing opioids for chronic pain—United States. 2016, JAMA, 315, 1624, 10.1001/jama.2016.1464

Benyamin, 2008, Opioid complications and side effects, Pain Physician, 11, S105, 10.36076/ppj.2008/11/S105